Delivery Order SPE2DB20D1004-SPE2DB25FNFXA

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,962.91 firm fixed-price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,830.24 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335.54 firm fixed-price contract provides for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication, with a completion date of February 14, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,129.68 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of May 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,395.16 firm fixed-price delivery order is for RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,196.56 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a medical product, with a completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,190.13 firm-fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,552.04 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of January 2, 2025. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm-fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a specialty medication, with a completion date of November 22, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET medical products. The contract has a completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFXA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,545.80 firm fixed-price delivery order is for RINVOQ ER 30 MG TABLET UU 30S and has an ultimate completion date of March 27, 2025.

The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas, enabling efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 6/29/25, 1:10 AM